Health
Fluvoxamine may prevent serious illness in COVID-19 patients – China.org.cn
CHICAGO, Nov. 13 (Xinhua) — Researchers at Washington University School of Medicine in St. Louis have found in a preliminary study that the drug fluvoxamine seems to prevent some of the most serious complications of COVID-19 patients and make hospitalization and the need for supplemental oxygen less likely.
In an innovative twist to research during the pandemic, the study, involving 152 patients infected with SAR-CoV-2, the virus that causes COVID-19, was conducted remotely. When a symptomatic…
Continue Reading
-
Noosa News17 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Business22 hours agoAre BHP shares are buy after its results?
-
Noosa News23 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business13 hours agoWhere next for the CBA share price?